Circulating Tumor Cells: State-of-the-art Update on Technologies and Clinical Applications Kristofor YapEvan N. CohenJoseph D. Khoury Molecular Testing and Diagnostics (J Khoury, Section Editor) 30 July 2019 Pages: 353 - 357
Liquid Biopsy by Next-Generation Sequencing: a Multimodality Test for Management of Cancer Hanadi El AchiJoseph D. KhourySanam Loghavi Molecular Testing and Diagnostics (J Khoury, Section Editor) 25 July 2019 Pages: 358 - 367
Immunohistochemistry Innovations for Diagnosis and Tissue-Based Biomarker Detection Narittee SukswaiJoseph D. Khoury Molecular Testing and Diagnostics (J Khoury, Section Editor) 23 July 2019 Pages: 368 - 375
Philadelphia-Negative Myeloproliferative Neoplasms: Laboratory Workup in the Era of Next-Generation Sequencing Zhuang ZuoShaoying LiC. Cameron Yin Molecular Testing and Diagnostics (J Khoury, Section Editor) 06 August 2019 Pages: 376 - 385
Acute Myeloid Leukemia: from Mutation Profiling to Treatment Decisions Courtney DiNardoCurtis Lachowiez Molecular Testing and Diagnostics (J Khoury, Section Editor) 26 July 2019 Pages: 386 - 394
Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors Marjan YaghmaieCecilia CS Yeung Molecular Testing and Diagnostics (J Khoury, Section Editor) 28 August 2019 Pages: 395 - 404
The Role of PI3K Inhibition in Lymphoid Malignancies Gottfried von KeudellAlison J. Moskowitz B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (J Amengual, Section Editor) 29 July 2019 Pages: 405 - 413
IMiDs New and Old Samuel YamshonJia Ruan B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (J Amengual, Section Editor) 13 July 2019 Pages: 414 - 425
Mechanisms of Resistance to Monoclonal Antibodies (mAbs) in Lymphoid Malignancies Pallawi TorkaMathew BarthFrancisco J. Hernandez-Ilizaliturri B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (J Amengual, Section Editor) 26 September 2019 Pages: 426 - 438
Chromatin-Remodeled State in Lymphoma Yuxuan LiuYulissa GonzalezJennifer E. Amengual B-Cell NHL, T-Cell NHL, and Hodgkin Lymphoma (J Amengual, Section Editor) 06 September 2019 Pages: 439 - 450
Multi-Specific CAR Targeting to Prevent Antigen Escape Zachary WalshSavannah RossTerry J. Fry CART and Immunotherapy (M Ruella and P Hanley, Section Editors) 22 July 2019 Pages: 451 - 459
Novel Therapies in Myeloproliferative Neoplasms (MPN): Beyond JAK Inhibitors Minas P. EconomidesSrdan VerstovsekNaveen Pemmaraju Myeloproliferative Neoplasms (B Stein, Section Editor) 01 August 2019 Pages: 460 - 468
Venetoclax for the Treatment of Chronic Lymphocytic Leukemia Herbert Eradat Chronic Lymphocytic Leukemias (N Jain, Section Editor) 11 September 2019 Pages: 469 - 476